SCHEMBL365258

SCHEMBL365258

NC(=O)c1c2ccc(C(=O)O)cc2n2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.42
PTGS2 P35354 1/20 0.41
FNTA P49354 3/20 0.40
FNTB P49356 3/20 0.40
MEN1 O00255 2/20 0.40
ALDH1A1 P00352 2/20 0.40
KMT2A Q03164 2/20 0.40
APAF1 O14727 1/20 0.40
MAPT P10636 1/20 0.40
G6PD P11413 1/20 0.40
PABPC1 P11940 1/20 0.40
CACNA1B Q00975 1/20 0.40
APBA1 Q02410 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
UBA2 Q9UBT2 1/20 0.40
PLA2G10 O15496 1/20 0.40
BAZ2B Q9UIF8 1/20 0.39
BAZ2A Q9UIF9 1/20 0.39
EGFR P00533 3/20 0.39
IDO1 P14902 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367763 0.93 BAZ2B (0.45) KDM4EPTGS2FNTAFNTBMEN1
SCHEMBL366810 0.90 PTGS2 (0.45) KDM4EPTGS2FNTAFNTBMEN1
SCHEMBL365934 0.90 KDM4E (0.45) KDM4EPTGS2FNTAFNTBMEN1
SCHEMBL367329 0.87 BAZ2B (0.47) KDM4EMEN1ALDH1A1KMT2AAPAF1
SCHEMBL365916 0.84 KDM4E (0.40) KDM4EMEN1ALDH1A1KMT2AAPAF1
SCHEMBL365634 0.84 CES1 (0.38) KDM4EMEN1ALDH1A1KMT2AAPAF1
SCHEMBL365470 0.84 EGFR (0.45) KDM4EMEN1ALDH1A1KMT2AAPAF1
SCHEMBL367200 0.82 KDM4E (0.55) KDM4EPTGS2MEN1ALDH1A1KMT2A
SCHEMBL364338 0.82 MAPT (0.47) KDM4EMEN1ALDH1A1KMT2AAPAF1
SCHEMBL366875 0.80 EGFR (0.42) KDM4EPTGS2FNTAFNTBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO claimed
WO-2012007008-A1 INHIBITORS OF HDME EPITHERAPEUTICS APS (DK) 2012-01-19 WO disclosed